A British clinical trial conducted at University College London indicates that an annual blood test screening postmenopausal women for ovarian cancer, could reduce death rates by as much as 20%. According to lead researcher Dr. Ian Jacobs, ovarian cancer has a poor prognosis, as it is often diagnosed at an advanced stage. While further research pertaining to this new blood test screening mechanism is required, Dr. Jacobs states that "this is the first time that there has been evidence of a reduction in deaths from ovarian cancer through early detection by screening."
To read more about this study, click here.
No comments:
Post a Comment